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Objectives This study was aimed at investigating whether a fractional flow reserve (FFR)-guided SYNTAX score (SS), termed
“functional SYNTAX score” (FSS), would predict clinical outcome better than the classic SS in patients with multi-
vessel coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI).
Background The SS is a purely anatomic score based on the coronary angiogram and predicts outcome after PCI in patients
with multivessel CAD. FFR-guided PCI improves outcomes by adding functional information to the anatomic in-
formation obtained from the angiogram.
Methods The SS was prospectively collected in 497 patients enrolled in the FAME (Fractional Flow Reserve versus Angiog-
raphy for Multivessel Evaluation) study. FSS was determined by only counting ischemia-producing lesions (FFR
0.80). The ability of each score to predict major adverse cardiac events (MACE) at 1 year was compared.
Results The 497 patients were divided into tertiles of risk based on the SS. After determining the FSS for each patient,
32% moved to a lower-risk group as follows. MACE occurred in 9.0%, 11.3%, and 26.7% of patients in the low-,
medium-, and high-FSS groups, respectively (p  0.001). Only FSS and procedure time were independent predic-
tors of 1-year MACE. FSS demonstrated a better predictive accuracy for MACE compared with SS (Harrell’s C of
FSS, 0.677 vs. SS, 0.630, p  0.02; integrated discrimination improvement of 1.94%, p  0.001).
Conclusions Recalculating SS by only incorporating ischemia-producing lesions as determined by FFR decreases the number
of higher-risk patients and better discriminates risk for adverse events in patients with multivessel CAD undergo-
ing PCI. (Fractional Flow Reserve versus Angiography for Multivessel Evaluation [FAME]; NCT00267774) (J Am
Coll Cardiol 2011;58:1211–8) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.06.020As a result of the reduction of repeat revascularization after
percutaneous coronary intervention (PCI) due to drug-
eluting stents, a large and growing number of patients with
multivessel coronary artery disease (CAD) are undergoing
PCI (1,2). However, the long-term safety and efficacy of
these procedures remain controversial. Therefore, appropri-
ate selection of target vessels and of methods for revascu-
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accepted June 14, 2011.larization is critical to obtain optimal clinical outcomes in
patients with multivessel CAD.
The SYNTAX score (SS) is an anatomic scoring system
based on the coronary angiogram, which not only quantifies
lesion complexity, but also predicts outcome after PCI in
patients with multivessel CAD and/or left main disease
(2–5). The SS allows prospective risk stratification of
patients with multivessel CAD undergoing PCI. However,
the SS has several inherent limitations because it is angiog-
See page 1219
raphy based (6). Recent studies have shown that many
angiographically significant lesions are not hemodynami-
cally significant, and stenting these stenoses results in worse
outcomes (7–9). The FAME (Fractional Flow Reserve
Versus Angiography in Multivessel Evaluation) study dem-
onstrated that treatment based on fractional flow reserve
(FFR) measurement in addition to angiography can de-
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diac events (MACE) in patients
with multivessel CAD (10–12).
The aim of this study was to
determine whether an FFR-
guided SYNTAX score, termed
“functional SYNTAX score”
(FSS) and defined as a recalcu-
lated SS counting only ischemia-
producing lesions as assessed by
FFR, is a better predictor of
1-year clinical outcome in pa-
tients with multivessel CAD un-
dergoing PCI.
Methods
Study design and population.
This study was performed by re-
analyzing the patients in the
FFR-guided arm of the FAME
study. In brief, FAME was a
multicenter trial designed to in-
vestigate PCI outcomes in 1,005
patients with multivessel CAD
(10). All patients were randomly assigned to angiography-
guided PCI (n  497) or FFR-guided PCI (n  509).
atients assigned to angiographic guidance underwent
tenting of all indicated lesions with drug-eluting stents. In
atients assigned to FFR guidance, FFR was measured in
ach diseased coronary artery, and stents were placed only if
he FFR was 0.80. Patients with angiographically signif-
cant left main CAD, previous coronary artery bypass graft
CABG) surgery, cardiogenic shock, or extremely tortuous
r calcified coronary arteries were excluded. The FAME
tudy protocol was approved by the internal review board or
thics committee of each participating center.
The SS for each patient was calculated by 3 interventional
ardiologists from different centers to assess interobserver
eproducibility; the cardiologists were blinded to the base-
ine clinical characteristics, procedural data, clinical out-
omes, and previously calculated SS. The lesions selected for
his calculation were based on the previous FAME study
10). From the baseline diagnostic angiogram, each coro-
ary lesion producing 50% diameter stenosis in vessels
1.5 mm by visual estimation was scored separately using
he SS score algorithm from its website, and individual
cores were added to provide the overall SS (4,13). FSS was
alculated by separately adding the individual scores of
esions with an actual value of FFR 0.80 and ignoring
esions with FFR 0.80. To assess intraobserver reproduc-
bility, angiograms were reanalyzed by the same interven-
ional cardiologist in 1 center at 8 weeks after the first
nalysis. The investigator remained blinded to the results of
Abbreviations
and Acronyms
AUC  area under the
curve
CABG  coronary artery
bypass graft
CAD  coronary artery
disease
CI  confidence interval
FFR  fractional flow
reserve
FSS  functional SYNTAX
score
IDI  integrated
discrimination improvement
MACE  major adverse
cardiac event(s)
MI  myocardial infarction
PCI  percutaneous
coronary intervention
ROC  receiver-operator
characteristic
SS  SYNTAX scorehe first analysis. wrocedural details. PCI was performed using standard
echniques. Antiplatelet and antithrombotic agents were pre-
cribed according to current PCI guidelines (14). FFR was
easured with a coronary pressure guidewire (Radi, St. Jude
edical, Uppsala, Sweden) and defined as the ratio between
ean distal coronary pressure and mean aortic pressure, both
easured simultaneously at maximal hyperemia induced by
ntravenous adenosine, administered at 140 g/kg/min
through a central vein. Hyperemic pressure pull-back record-
ings were performed as described previously (15,16). Quanti-
tative coronary angiography was performed offline.
Study endpoints. The primary endpoint was the rate of
MACE at 1 year. MACE was defined as a composite of
death, myocardial infarction (MI), or any repeat revascular-
ization. Secondary endpoints included individual compo-
nents of MACE. Death was defined as all-cause mortality.
MI was defined as a 3-fold or greater elevation of creatine
kinase-myocardial band (CK-MB) level or new Q waves in
2 contiguous leads of the electrocardiogram (17). Total
CK and CK-MB levels were measured in all patients
between 12 and 24 h after PCI. Repeat revascularization
included repeat PCI or CABG. After discharge, follow-up
was performed at 1 month, 6 months, and 1 year.
Statistical analyses. All variables were stratified according to
SS tertiles. Three groups of FSS were divided by the same
cutoff score based on SS tertiles. Continuous variables, includ-
ing SS, are expressed as mean SD and were compared using
-way ANOVA. Categorical data are presented as frequency
%) and were compared using the Pearson chi-square test or
he Fisher exact test, appropriately. The reproducibility of
YNTAX scoring was evaluated by calculating intraobserver
nd interobserver reliability using intraclass correlation.
eceiver-operator characteristic (ROC) curves analysis and
ntegrated discrimination improvement (IDI) were used to
ompare the performance and predictive accuracy of the SS
nd FSS for MACE during 1-year follow-up (18). Multivar-
ate logistic regression analysis also was used to assess indepen-
ent predictors of MACE at 1 year. The parameters analyzed
n multivariate analysis were selected when the p value was
0.10 in the univariate analysis. Differences were considered
o be statistically significant when the 2-sided p values were
0.05. All statistical analyses were performed using SPSS
ersion 15.0 for Windows (SPSS Inc., Chicago, Illinois) and
AS version 9.1 (SAS Institute Inc., Cary, North Carolina).
esults
YNTAX score according to risk groups. The SS was
rospectively measured in 497 patients of the 509 patients in
he FFR-guided arm of the FAME study. Twelve cases
ere excluded because of missing angiograms. The range,
ean, and median SS were 4 to 43, 14.8  6.0, and 13.8,
espectively, whereas those for FSS were 0 to 43, 11.3 
.9, and 10.5, respectively. In this study, the 497 patients
ere divided into tertiles (intertertile range: 12 to 16) of risk
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September 13, 2011:1211–8 Functional SYNTAX Score in Multivessel CADbased on the SS, namely low, medium, and high SS (34%,
n  167; 34%, n  167; and 32%, n  163, respectively)
nd analyzed. After incorporating FFR into the SS to
alculate FSS, 32% of patients moved from a higher-risk
roup to a lower-risk group as follows: 23% of the highest
S tertile moved to the medium-risk FSS group and 15%
oved to the lowest-risk FSS group, whereas 59% of the
iddle SS tertile moved to the lowest-risk FSS group.
hus, after calculating the FSS, 3 new groups were created
s follows: low FSS, 59% (n  290), medium FSS, 21%
n  106), and high FSS, 20% (n  101) (Fig. 1).
eproducibility of the SYNTAX score. The mean values
f the SS calculated by 3 cardiologists were 14.1  5.4, 14.2 
.7, and 16.5  7.4, whereas those of FSS were 10.6  6.6,
0.9  7.5, and 12.4  8.1, respectively. An interobserver
reliability of classic SS using the intraclass correlation
analysis was 0.594, 95% confidence interval (CI): 0.515 to
0.661 (p 0.0001), and that of FSS was increased as 0.713,
95% CI: 0.664 to 0.756 (p  0.0001).
With respect to intraobserver variability, the value of the
SS in the first measurement was 14.2  6.7 versus 14.6 
7.3 for the second measurement. The mean difference of
intraobserver variability using paired t test for the classic SS
was 0.358  3.175 (p  0.013), and that of the FSS was
0.307  3.024 (p  0.025). An intraobserver reliability of
classic SS using the intraclass correlation analysis was 0.946,
95% CI: 0.9535 to 0.955 (p 0.0001), and that of FSS was
0.961, 95% CI: 0.953 to 0.967 (p  0.0001).
Baseline characteristics and procedural results. Baseline
clinical, angiographic, and procedural characteristics of the
study population are summarized and stratified in Tables 1 and 2.
Baseline clinical characteristics were not different among the
3 groups. However, the number of indicated lesions per
patient, involvement of proximal left anterior descending
coronary artery, and indicators of procedure complexity,
such as procedure time, amount of contrast agent used,
Figure 1 Proportions of Study Population
Proportions of the study population according to the tertiles of the classic SYNTAX
FFR into the SS to calculate FSS, 32% of patients moved from a higher-risk group
lowest-risk FSS group, whereas 59% of the medium-risk SS tertile moved to the lonumber of drug-eluting stents used, and total stent length
were significantly larger in the higher-SS or -FSS group,
reflecting the higher calculated score for these patients.
1-year outcomes according to the SS and FSS. Death or
MI occurred in 4.8%, 7.5%, and 15.8% of patients with low,
medium, and high FSS, respectively (p  0.005). Although
a similar trend was observed in the SS groups, the differ-
ences did not achieve statistical significance (5.4%, 6.0%,
and 11.7% in the low-, medium-, and high-SS groups, p 
0.06) (Fig. 2). The rate of any repeat revascularization was
4.5% and 3.8% in the low and medium FSS groups,
respectively, compared with 12.9% in the high-FSS group,
respectively (p  0.005). A similar pattern was observed in
the SS groups (3.6%, 4.2%, and 10.4% in the low-,
medium-, and high-SS groups, p  0.02). The rate of
MACE as a composite of death, MI, and repeat revascu-
larization was 9.0%, 11.3%, and 26.7% in the low-,
medium-, and high-FSS groups (p  0.001) and 8.4%,
10.2%, and 20.9% in the low-, medium-, and high-SS
groups, respectively (p  0.001) (Fig. 2).
Predictors of outcomes. Logistic regression analysis was
used to define the predictors of MACE at 1 year (Table 3).
Comorbidity with peripheral vascular disease, procedure
time, contrast volume used, the SS, and FSS were related to
MACE in univariate analysis. However, after multivariate
adjustment, the independent predictors of 1-year MACE
were FSS (relative risk: 1.14, 95% CI: 1.04 to 1.25, p 
0.006) and procedure time (relative risk: 1.01, 95% CI: 1.01
to 1.02, p  0.003).
SS versus FSS. ROC analysis for clinical outcomes at 1
year is shown in Figure 3. In the ROC for 1-year MACE,
the area under the curve (AUC) for FSS was larger than that
of SS (Harrell’s C of FSS, 0.677 vs. SS, 0.630, p  0.02)
(Fig. 3A). FSS demonstrated a better predictive accuracy for
MACE compared with SS (IDI of 1.94%, p  0.001). A
imilar result was observed in the ROC for death or MI; the
(SS) (A) and those of the functional SYNTAX score (FSS) (B). After incorporating
wer-risk group as follows: 38% of the highest SS tertile moved to the medium- or
isk FSS group.score
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Functional SYNTAX Score in Multivessel CAD September 13, 2011:1211–8AUC for FSS was larger than that of SS (0.676 vs. 0.621,
p  0.017) (Fig. 3B), and IDI of 1.30%, p  0.0008. The
results for any repeat revascularization showed Harrell’s C of
FSS of 0.657 versus SS, 0.627 (p 0.329) (Fig. 3C), and IDI
f 0.54% (p  0.02). When the clinical SS (19), which added
linical parameters to the classic SS, is compared with the FSS,
he AUC for 1-year MACE for the FSS was larger than that
f the clinical SS (0.687 vs. 0.608, p  0.008).
Discussion
The major findings in the current study are that the FSS
decreases the number of highest-risk patients as assessed by
the classic SS while better discriminating risk for adverse
cardiac events in patients with multivessel CAD undergoing
PCI. Furthermore, the FSS is an independent predictor of
1-year MACE in these patients. Finally, the inter- and
intraobserver variability of the FSS is better than that for the
SS. These findings could have significant clinical implica-
tions on decision making regarding the choice of revascu-
larization strategies in patients with multivessel CAD.
Recently the SS, which is derived from coronary anatomy
and lesion characteristics, was introduced to quantify lesion
Baseline and Procedural Characteristics of theTable 1 Baseline and Procedural Characteri
Low SS
(n  167
Clinical
Age, yrs 64 10
Male 124 (74
Diabetes 32 (19
Hypertension 103 (62
Hypercholesterolemia 119 (72
Current smoking 54 (32
Positive family history 73 (45
Previous myocardial infarction 67 (40
Previous PCI 47 (28
Peripheral vascular disease 12 (7)
Left ventricular ejection fraction, % 57 11
Angiographic
Indicated lesions per patient 2.4 0.
50%–70% narrowing 169 (42
70%–90% narrowing 160 (40
90%–99% narrowing 59 (15
Total occlusion 10 (3)
Involvement of proximal LAD lesion 36 (22
SYNTAX score 9.1 1.
Procedural
Procedure time, min* 56 28
Contrast agent used, ml 233 10
Drug-eluting stents used per patient 1.4 0.
Total stent length, mm 25 18
Average stent diameter, mm 3.0 0.
Values are mean  SD or n (%). Patients were divided into tertiles acc
introduction of first catheter until removal of last guiding catheter.
LAD  left anterior descending coronary artery; PCI  percutaneoucomplexity and to predict early and late clinical outcomes Cafter PCI in patients with multivessel CAD and/or left
main disease (2,4). Methods of revascularization can be
decided according to the SS and improve clinical outcome.
However, it is well known that angiographic lesion assess-
ment has several inherent limitations (6). The severity of a
significant number of lesions is underestimated or overesti-
mated by only using angiographic information. Moreover,
PCI of a functionally nonsignificant stenosis is not of
benefit to the patient, either from a prognostic or from a
symptomatic point of view (7). In the FAME study,
FFR-guided PCI in multivessel CAD was associated with a
favorable 1- and 2-year clinical outcome compared with
PCI guided by angiography alone (11).
In the current study, by recalculating the SS after counting
only ischemia-producing lesions with FFR 0.80, termed
functional SYNTAX score” (FSS), 32% of studied patients
oved from higher-risk groups by SS to lower-risk groups by
SS (Fig. 1). In particular, 23% of patients in the highest SS
ertile moved to the middle group, 15% of the highest tertile
oved to the lowest group, and 59% of patients in the middle
S tertile moved to the lowest group. These changes were
riven in large part by the conversion of angiographic 3-vessel
ic SS Groupsof the Classic SS Groups
Medium SS
(n  167)
High SS
(n  163) p Value
65 10 65 10 0.40
130 (78) 122 (75) 0.72
39 (23) 49 (30) 0.07
98 (59) 102 (63) 0.75
122 (74) 115 (71) 0.87
46 (28) 36 (22) 0.12
58 (35) 69 (44) 0.16
51 (31) 64 (39) 0.15
49 (30) 47 (29) 0.96
16 (10) 19 (12) 0.40
57 11 57 11 0.81
3.0 0.9 3.5 1.3 0.001
235 (47) 225 (39)
170 (34) 220 (38)
70 (14) 79 (14)
22 (5) 52 (9)
74 (44) 100 (61) 0.001
13.9 1.2 21.6 4.7 0.001
69 44 85 50 0.001
265 111 321 161 0.001
1.6 0.9 2.2 1.1 0.001
31 20 43 26 0.001
2.9 0.4 2.9 0.3 0.43
to the SYNTAX score (SS). *Procedure time was defined as time from
ary intervention.Classstics
)
)
)
)
)
)
)
)
)
7
)
)
)
)
9
4
9
4
ordingAD to functional 1- or 2-vessel CAD.
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September 13, 2011:1211–8 Functional SYNTAX Score in Multivessel CADWith changes in the relative proportions of each risk
group, the rate of MACE was accordingly increased from
low- and medium-risk groups to the highest-risk group; this
difference was greater in the FSS groups compared with the
classic SS groups. The rate of death or myocardial infarction
as a critical hard endpoint was significantly different in the
FSS groups unlike the SS groups (Fig. 2). Because nearly all
the ischemia-producing lesions were sufficiently revascular-
ized at the time of the initial PCI, and the rate of repeat
revascularization was very low in the low- and medium-FSS
groups, as it was in the SS groups, the predictive accuracy of
FSS for repeat revascularization was not statistically differ-
ent from SS. However, the FSS did predict repeat revascu-
larization in that the highest-FSS group had a significantly
higher repeat revascularization rate compared with the
lowest and middle groups. The MACE rate of the patients
who moved from the high-risk group based on the classic SS
to the low- and medium-risk groups based on the FSS was
significantly lower when compared with those patients who
remained in the high-risk group (11.3% vs. 26.7%, p 
0.028). Therefore, the FSS can not only help to more
accurately stratify the risk in each patient with multivessel
CAD, but it is also more closely related to prognosis after
Baseline and Procedural Characteristics of theTable 2 Baseline and Procedural Characteri
Low FSS
(n  290
Clinical
Age, yrs 64 10
Male 216 (75
Diabetes 67 (23
Hypertension 174 (60
Hypercholesterolemia 209 (73
Current smoking 88 (30
Positive family history 120 (42
Previous myocardial infarction 107 (37
Previous PCI 95 (33
Peripheral vascular disease 21 (10
Left ventricular ejection fraction, % 58 11
Angiographic
Indicated lesions per patient 2.8 0.9
50%–70% narrowing 392 (49
70%–90% narrowing 282 (35
90%–99% narrowing 99 (13
Total occlusion 27 (3)
Involvement of proximal LAD lesion 97 (33
SYNTAX score 6.7 3.5
Procedural
Procedure time, min* 59 37
Contrast agent used, ml 239 10
Drug-eluting stents used per patient 1.3 0.9
Total stent length, mm 25 18
Average stent diameter, mm 2.9 0.4
Values are mean SD or n (%). Patients were divided into 3 groups us
as time from introduction of first catheter until removal of last guidin
FSS  functional SYNTAX score; other abbreviations as in Table 1.revascularization according to risk group.The decision on whether to perform PCI or CABG in
patients with multivessel CAD remains highly controver-
sial. If the 2010 European myocardial revascularization
guidelines are applied to patients in this study (20), 43% (29
of 69 patients) of patients in whom CABG would be
recommended due to 3-vessel CAD with an SS 22 would
move to a lower-risk group after calculation of the FSS and
thereby might have another option. In contrast, when the
fact is considered that the patients with high FSS had the
worst 1-year outcome after PCI in all studied groups,
surgical revascularization could be considered in the high-
risk patients with multivessel CAD classified by FSS, and
hopefully improve outcomes. This hypothesis will need to
be tested by another randomized trial.
In multivariate analysis, the independent predictors of
cumulative 1-year MACE were FSS and procedure time.
The result was the same when this analysis was repeated to
predict only the hard endpoints of death and MI, or to
predict 1-year MACE excluding periprocedural MI. In the
latter analysis, the presence of diabetes was added to the
original 2 predictors. The ROC and IDI analyses demon-
strate a superior ability of the FSS to predict death or MI,
and MACE at 1 year compared with the classic SS. The
roupsof the FSS Groups
Medium FSS
(n  106)
High FSS
(n  101) p Value
66 10 65 11 0.31
80 (76) 80 (79) 0.63
21 (20) 32 (32) 0.11
63 (59) 66 (65) 0.60
72 (68) 75 (75) 0.51
27 (26) 21 (21) 0.17
38 (36) 42 (42) 0.47
35 (33) 40 (40) 0.64
19 (18) 29 (29) 0.02
7 (7) 11 (11) 0.53
57 11 56 12 0.55
2.9 0.9 3.6 1.4 0.001
125 (40) 112 (31)
114 (37) 154 (43)
57 (18) 52 (14)
14 (5) 43 (12)
53 (50) 60 (59) 0.001
13.9 1.3 21.7 5.0 0.001
72 33 99 54 0.001
281 122 361 173 0.001
2.0 0.9 2.5 1.1 0.001
40 19 49 27 0.001
3.0 0.3 2.9 0.3 0.24
e tertile values of classic SS in Table 1. *Procedure time was defined
ter.FSS Gstics
)
)
)
)
)
)
)
)
)
)
)
)
)
)
2
ing saminterobserver reproducibility of FSS also was better than
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Functional SYNTAX Score in Multivessel CAD September 13, 2011:1211–8that of SS, because it eliminates functionally insignificant
lesions, resulting in fewer lesions requiring inclusion and
description by the SS and therefore fewer chances for
disagreement. The FSS has better predictive accuracy and
reliability than the classic SS. Therefore, the selection of
target vessels, the method for revascularization, and the
determination of prognosis in patients with multivessel
CAD are improved by calculating the FSS in daily practice.
Figure 2 Outcomes According to the SS
The rates of death or myocardial infarction (MI) (A), and the rates of major
adverse cardiac events (MACE), as composite of death, MI, or any repeat
revascularization including repeat percutaneous coronary intervention and coro-
nary artery bypass graft (B) according to the tertiles of SS and FSS. The rate of
death or MI as a critical hard endpoint was significantly different in the FSS
groups unlike the SS groups. The rate of MACE was accordingly increased for
the highest-risk group; this trend was attenuated in the FSS groups compared
with the classic SS groups. *p  0.01, **p  0.001. Abbreviations as in
Figure 1.
Predictors for Composites of Death, MI, RepeatTable 3 Predictors for Composites of Death
Univariate Vari
Relative Risk 95%
Diabetes 1.61 0.93–2
Hypertension 1.61 0.92–2
Peripheral vascular disease 2.11 1.02–4
Procedure time 1.01 1.01–1
Contrast agent used 1.01 1.00–1
Classic SYNTAX score 1.07 1.03–1
Functional SYNTAX score 1.08 1.05–1CABG  coronary artery bypass graft; CI  confidence interval; MI  myocarThe FSS still does not include clinical patient character-
istics. Recent studies have demonstrated that the incorpo-
ration of clinical risk factors into scoring systems, such as
the clinical SS or New Risk Stratification score, improves
the predictability and accuracy of the SS (19,21). However,
this was not the subject of this study and will have to be
investigated further.
Study limitations. First, because the current study is re-
stricted to 1-year clinical outcome, unscored lesions by FFR
guidance can progress to future adverse outcome beyond
this time. However, a previous report demonstrated good
clinical outcome up to 5 years in lesions deferred based on
FFR guidance (7). Second, this study was not a direct
comparison of outcomes between FFR-guided PCI and
CABG in patients with multivessel CAD. Therefore, a new
randomized trial would be necessary to prove that applica-
tion of the FSS would result in better outcomes in patients
undergoing PCI compared with CABG. Third, measuring
FFR to calculate the FSS is inherently invasive and adds
complexity, but the information is extremely valuable, and
we believe it outweighs the added risk. Fourth, the FFR
comparison was against visual calculation of the syntax score
same as the SYNTAX (Synergy Between Percutaneous
Coronary Intervention With Taxus and Cardiac Surgery)
trial, and that if quantitative coronary angiography had been
used, this may have affected the number of reclassified
patients. Finally, this study population had 2- and 3-vessel
disease, whereas the SYNTAX trial included patients with
3-vessel disease and/or left main disease. Therefore, direct
comparison between studies or analysis using the same
cutoff score as SYNTAX trial were impossible. However,
patients in this study could still be stratified into low-,
medium-, and higher-risk groups based on the FSS.
Conclusions
Compared with the classic SS, the FSS, which is obtained
by counting only ischemia-provoking lesions, has better
reproducibility, has better prognostic value, and increases
the proportion of patients with multivessel CAD who fall
into the lowest risk for adverse events after PCI.
or CABG at 1 YearRepeat PCI, or CABG at 1 Year
Multivariate Variables
p Value Relative Risk 95% CI p Value
0.09 1.49 0.81–2.75 0.20
0.09 1.26 0.69–2.28 0.45
0.045 1.54 0.67–3.51 0.31
0.001 1.01 1.01–1.02 0.003
0.01 1.00 0.99–1.01 0.61
0.001 0.92 0.83–1.02 0.11
0.001 1.14 1.04–1.25 0.006PCI,, MI,
ables
CI
.80
.80
.36
.02
.01
.11
.12dial infarction; PCI  percutaneous coronary intervention.
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